1. Home
  2. TIVC vs CDT Comparison

TIVC vs CDT Comparison

Compare TIVC & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIVC
  • CDT
  • Stock Information
  • Founded
  • TIVC 2016
  • CDT 2019
  • Country
  • TIVC United States
  • CDT United States
  • Employees
  • TIVC N/A
  • CDT N/A
  • Industry
  • TIVC Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CDT Biotechnology: Pharmaceutical Preparations
  • Sector
  • TIVC Health Care
  • CDT Health Care
  • Exchange
  • TIVC Nasdaq
  • CDT Nasdaq
  • Market Cap
  • TIVC 4.0M
  • CDT 4.6M
  • IPO Year
  • TIVC 2021
  • CDT N/A
  • Fundamental
  • Price
  • TIVC $2.98
  • CDT $0.63
  • Analyst Decision
  • TIVC
  • CDT
  • Analyst Count
  • TIVC 0
  • CDT 0
  • Target Price
  • TIVC N/A
  • CDT N/A
  • AVG Volume (30 Days)
  • TIVC 3.1M
  • CDT 1.8M
  • Earning Date
  • TIVC 08-14-2025
  • CDT 08-14-2025
  • Dividend Yield
  • TIVC N/A
  • CDT N/A
  • EPS Growth
  • TIVC N/A
  • CDT N/A
  • EPS
  • TIVC N/A
  • CDT N/A
  • Revenue
  • TIVC $462,000.00
  • CDT N/A
  • Revenue This Year
  • TIVC N/A
  • CDT N/A
  • Revenue Next Year
  • TIVC N/A
  • CDT N/A
  • P/E Ratio
  • TIVC N/A
  • CDT N/A
  • Revenue Growth
  • TIVC N/A
  • CDT N/A
  • 52 Week Low
  • TIVC $2.43
  • CDT $0.61
  • 52 Week High
  • TIVC $15.64
  • CDT $274.80
  • Technical
  • Relative Strength Index (RSI)
  • TIVC 39.13
  • CDT 14.48
  • Support Level
  • TIVC $2.81
  • CDT $1.47
  • Resistance Level
  • TIVC $3.19
  • CDT $1.36
  • Average True Range (ATR)
  • TIVC 0.18
  • CDT 0.11
  • MACD
  • TIVC -0.00
  • CDT -0.05
  • Stochastic Oscillator
  • TIVC 20.00
  • CDT 2.23

About TIVC Tivic Health Systems Inc.

Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.

About CDT Conduit Pharmaceuticals Inc.

CDT Equity Inc, formerly Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Share on Social Networks: